• Ginkgo Biloba Compound Cocktail Extends Yeast Lifespan via M

  2026-07-21

  This study demonstrates that a network pharmacology-guided cocktail of four Ginkgo biloba compounds synergistically improves mitochondrial function, reduces oxidative stress, and extends chronological lifespan in yeast. The findings highlight the value of multi-component phytochemical strategies for targeting cellular aging mechanisms and optimizing anti-aging interventions.

• Alfuzosin HCl: Mechanistic Insight and Translational Strateg

  2026-07-21

  This thought-leadership article explores the mechanistic underpinnings and translational potential of Alfuzosin hydrochloride as a selective α1 adrenoceptor antagonist for benign prostatic hyperplasia (BPH) research. Integrating the latest evidence from gastroretentive formulation studies and advanced in vitro workflows, the article offers strategic guidance for researchers aiming to maximize clinical impact while minimizing experimental pitfalls.

• DAF-2 Diacetate in Nitric Oxide Imaging: Beyond Quantificati

  2026-07-20

  Explore how DAF-2 diacetate (4,5-Diaminofluorescein diacetate) enables advanced, high-sensitivity nitric oxide imaging and mechanistic studies. This article offers new scientific insight into dynamic NO signaling, integrating latest research and practical assay guidance.

• Resveratrol (SKU A4182): Enhancing Neuroprotection Assay Rig

  2026-07-20

  This article delivers scenario-driven guidance for researchers using Resveratrol (SKU A4182) in cell viability, proliferation, and cytotoxicity workflows. Integrating recent mechanistic and protocol advances, it demonstrates how this SIRT1 activator enables reproducible, sensitive, and interpretable assays in neurodegeneration research. Key vendor and protocol selection insights are provided for practical laboratory decision-making.

• Biotin-tyramide: Redefining Proximity Labeling Beyond IHC

  2026-07-19

  Explore how Biotin-tyramide advances biotin phenol–based proximity labeling, enabling high-resolution protein mapping beyond traditional immunohistochemistry (IHC) and ISH. This article uncovers recent methodological breakthroughs and practical insights for advanced cell biology assays.

• 10 mM dNTP Mixture: Precision Reagent for DNA Synthesis Work

  2026-07-18

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture streamlines challenging PCR, qPCR, and DNA sequencing protocols, ensuring high-fidelity results in demanding experimental systems. Leverage this equimolar nucleotide solution for reliable performance and simplified troubleshooting across molecular biology and emerging delivery assay applications.

• Carboplatin: Platinum-Based DNA Synthesis Inhibitor in Cance

  2026-07-17

  Carboplatin empowers preclinical oncology research through precise DNA synthesis inhibition, enabling robust modeling of tumor cell response and resistance mechanisms. Discover advanced workflow strategies, data-backed protocols, and troubleshooting tips that maximize the translational impact of this platinum-based agent from APExBIO.

• ML385: Selective NRF2 Inhibitor for Cancer and Oxidative Str

  2026-07-17

  ML385 is a selective NRF2 inhibitor used in non-small cell lung cancer and oxidative stress modulation research. It demonstrates robust inhibition of NRF2-dependent pathways, as shown in cell and animal models, and is supplied by APExBIO for preclinical applications.

• DiscoveryProbe Natural Product Library Plus: High-Content Sc

  2026-07-16

  DiscoveryProbe Natural Product Library Plus offers a rigorously validated, diverse set of 1,655 natural products for high throughput and high content screening. This resource enables rapid identification of cell-permeable bioactive compounds and selective modulators in drug discovery workflows. The library's pre-dissolved, quality-verified format minimizes assay variability and accelerates translational research.

• Ferrostatin-1 (Fer-1): Redefining Ferroptosis Assays in Canc

  2026-07-16

  Discover the advanced utility of Ferrostatin-1 (Fer-1) as a selective ferroptosis inhibitor in cancer and neurodegenerative disease models. This article uniquely analyzes how Fer-1 enables high-resolution mechanistic studies of oxidative lipid damage, integrating recent breakthroughs in ROS biology.

• Standardized Whole-Blood Stimulation for Immunometabolic Ana

  2026-07-15

  The featured study presents a standardized protocol for analyzing immune responses in human whole blood under metabolic modulation, enabling precise investigation of how metabolic pathways influence cytokine production. This methodological advance addresses previous limitations in reproducibility and scalability, offering a robust platform for immunometabolic research and translational applications.

• EGCG-Eluting 3D-Printed Calcium Phosphate Scaffolds for Bone

  2026-07-15

  This study demonstrates the use of 3D-printed tricalcium phosphate scaffolds for controlled delivery of (-)-Epigallocatechin gallate (EGCG), enhancing osteogenesis, anti-osteoclastogenesis, angiogenesis, and chemoprevention in vitro. These findings suggest a multifunctional approach to craniofacial bone defect repair after trauma or tumor excision.

• (S)-(+)-Dimethindene maleate: Technical Guide for M2 Antagon

  2026-07-14

  (S)-(+)-Dimethindene maleate provides selective antagonism at the muscarinic M2 and histamine H1 receptors, enabling precise dissection of autonomic and cardiovascular pathways in research models. Its use is indicated in receptor selectivity profiling and studies requiring minimized off-target effects at muscarinic M1, M3, and M4 subtypes. This compound is not intended for diagnostic or in vivo clinical applications.

• Protease Inhibitor Cocktail (100X H₂O, EDTA Plus): Precision

  2026-07-14

  Explore how Protease Inhibitor Cocktail (100X H₂O, EDTA Plus) enables uncompromised protein stability in advanced lipid droplet research. Learn why this protease inhibitor mixture is essential for high-fidelity extraction in dynamic cellular metabolism studies.

• 10058-F4: Targeted c-Myc-Max Dimerization Inhibitor Insights

  2026-07-13

  10058-F4 is a selective c-Myc-Max dimerization inhibitor shown to disrupt oncogenic transcriptional regulation, induce apoptosis via mitochondrial pathways, and suppress tumor growth in validated models. Its mechanism and workflow integration offer robust, reproducible support for acute myeloid leukemia and prostate cancer xenograft research.

16504 records 1/1101 page Next 12345 下5页 Last page